As collaboration between gastroenterologists and the pharmaceutical and medical device industries continues to grow, advisory boards, consulting, educational programs, and research partnerships have become increasingly common. These engagements enable clinicians to share real-world insights that help shape the development, evaluation, and adoption of new therapies and technologies, while also providing access to emerging science, professional networks, and opportunities to influence patient care.
The review emphasizes that industry collaboration can be valuable when conducted transparently and ethically. It provides practical guidance on evaluating advisory opportunities, understanding compensation and regulatory requirements, and managing potential conflicts of interest. Ultimately, the goal is to help gastroenterologists engage with industry in ways that uphold professional integrity, maintain patient trust, and ensure that clinical decision-making remains centered on patient outcomes.